Literature DB >> 21987776

Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis.

Paulina Aleksandrowicz1, Andrea Marzi, Nadine Biedenkopf, Nadine Beimforde, Stephan Becker, Thomas Hoenen, Heinz Feldmann, Hans-Joachim Schnittler.   

Abstract

Virus entry into host cells is the first step of infection and a crucial determinant of pathogenicity. Here we show that Ebola virus-like particles (EBOV-VLPs) composed of the glycoprotein GP(1,2) and the matrix protein VP40 use macropinocytosis and clathrin-mediated endocytosis to enter cells. EBOV-VLPs applied to host cells induced actin-driven ruffling and enhanced FITC-dextran uptake, which indicated macropinocytosis as the main entry mechanism. This was further supported by inhibition of entry through inhibitors of actin polymerization (latrunculin A), Na(+)/H(+)-exchanger (EIPA), and PI3-kinase (wortmannin). A fraction of EBOV-VLPs, however, colocalized with clathrin heavy chain (CHC), and VLP uptake was reduced by CHC small interfering RNA transfection and expression of the dominant negative dynamin II-K44A mutant. In contrast, we found no evidence that EBOV-VLPs enter cells via caveolae. This work identifies macropinocytosis as the major, and clathrin-dependent endocytosis as an alternative, entry route for EBOV particles. Therefore, EBOV seems to utilize different entry pathways depending on both cell type and virus particle size.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21987776      PMCID: PMC3189988          DOI: 10.1093/infdis/jir326

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  47 in total

Review 1.  Intracellular objects tracking.

Authors:  Yannis Kalaidzidis
Journal:  Eur J Cell Biol       Date:  2007-07-23       Impact factor: 4.492

Review 2.  Virus entry by macropinocytosis.

Authors:  Jason Mercer; Ari Helenius
Journal:  Nat Cell Biol       Date:  2009-05       Impact factor: 28.824

3.  High-resolution 3D quantitative analysis of caveolar ultrastructure and caveola-cytoskeleton interactions.

Authors:  Tobias Richter; Matthias Floetenmeyer; Charles Ferguson; Janette Galea; Jaclyn Goh; Margaret R Lindsay; Garry P Morgan; Brad J Marsh; Robert G Parton
Journal:  Traffic       Date:  2008-04-07       Impact factor: 6.215

Review 4.  Shaping cups into phagosomes and macropinosomes.

Authors:  Joel A Swanson
Journal:  Nat Rev Mol Cell Biol       Date:  2008-07-09       Impact factor: 94.444

5.  The mechanism of Axl-mediated Ebola virus infection.

Authors:  Masayuki Shimojima; Yasuhiro Ikeda; Yoshihiro Kawaoka
Journal:  J Infect Dis       Date:  2007-11-15       Impact factor: 5.226

6.  In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein.

Authors:  Hideki Ebihara; Steven Theriault; Gabriele Neumann; Judie B Alimonti; Joan B Geisbert; Lisa E Hensley; Allison Groseth; Steven M Jones; Thomas W Geisbert; Yoshihiro Kawaoka; Heinz Feldmann
Journal:  J Infect Dis       Date:  2007-11-15       Impact factor: 5.226

7.  Regulation of endothelial barrier function during flow-induced conversion to an arterial phenotype.

Authors:  Jochen Seebach; Gerald Donnert; Romy Kronstein; Sebastian Werth; Beata Wojciak-Stothard; Darryl Falzarano; Christof Mrowietz; Stefan W Hell; Hans-J Schnittler
Journal:  Cardiovasc Res       Date:  2007-05-04       Impact factor: 10.787

Review 8.  Non-classical use of clathrin during bacterial infections.

Authors:  P Cossart; E Veiga
Journal:  J Microsc       Date:  2008-09       Impact factor: 1.758

9.  Clathrin couture: fashioning distinctive membrane coats at the cell surface.

Authors:  Linton M Traub
Journal:  PLoS Biol       Date:  2009-09-08       Impact factor: 8.029

10.  Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus.

Authors:  Mohammad F Saeed; Andrey A Kolokoltsov; Alexander N Freiberg; Michael R Holbrook; Robert A Davey
Journal:  PLoS Pathog       Date:  2008-08-29       Impact factor: 6.823

View more
  112 in total

1.  Structural basis for Marburg virus neutralization by a cross-reactive human antibody.

Authors:  Takao Hashiguchi; Marnie L Fusco; Zachary A Bornholdt; Jeffrey E Lee; Andrew I Flyak; Rei Matsuoka; Daisuke Kohda; Yusuke Yanagi; Michal Hammel; James E Crowe; Erica Ollmann Saphire
Journal:  Cell       Date:  2015-02-26       Impact factor: 41.582

2.  Macropinocytosis and Clathrin-Dependent Endocytosis Play Pivotal Roles for the Infectious Entry of Puumala Virus.

Authors:  Sandy Bauherr; Filip Larsberg; Annett Petrich; Hannah Sabeth Sperber; Victoria Klose-Grzelka; Madlen Luckner; Walid Azab; Matthias Schade; Chris Tina Höfer; Maik Joerg Lehmann; Peter T Witkowski; Detlev H Krüger; Andreas Herrmann; Roland Schwarzer
Journal:  J Virol       Date:  2020-07-01       Impact factor: 5.103

3.  Large-Scale Screening and Identification of Novel Ebola Virus and Marburg Virus Entry Inhibitors.

Authors:  Manu Anantpadma; Jennifer Kouznetsova; Hang Wang; Ruili Huang; Andrey Kolokoltsov; Rajarshi Guha; Aaron R Lindstrom; Olena Shtanko; Anton Simeonov; David J Maloney; Wendy Maury; Douglas J LaCount; Ajit Jadhav; Robert A Davey
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

4.  Rab1a regulates sorting of early endocytic vesicles.

Authors:  Aparna Mukhopadhyay; Jose A Quiroz; Allan W Wolkoff
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-01-09       Impact factor: 4.052

5.  Identification of novel macropinocytosis inhibitors using a rational screen of Food and Drug Administration-approved drugs.

Authors:  Hui-Ping Lin; Bhupesh Singla; Pushpankur Ghoshal; Jessica L Faulkner; Mary Cherian-Shaw; Paul M O'Connor; Jin-Xiong She; Eric J Belin de Chantemele; Gábor Csányi
Journal:  Br J Pharmacol       Date:  2018-08-01       Impact factor: 8.739

Review 6.  Achieving cross-reactivity with pan-ebolavirus antibodies.

Authors:  Liam B King; Jacob C Milligan; Brandyn R West; Sharon L Schendel; Erica Ollmann Saphire
Journal:  Curr Opin Virol       Date:  2019-03-15       Impact factor: 7.090

7.  Severe fever with thrombocytopenia virus glycoproteins are targeted by neutralizing antibodies and can use DC-SIGN as a receptor for pH-dependent entry into human and animal cell lines.

Authors:  Heike Hofmann; Xingxing Li; Xiaoai Zhang; Wei Liu; Annika Kühl; Franziska Kaup; Samantha S Soldan; Francisco González-Scarano; Friedemann Weber; Yuxian He; Stefan Pöhlmann
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

8.  Pyridinyl imidazole inhibitors of p38 MAP kinase impair viral entry and reduce cytokine induction by Zaire ebolavirus in human dendritic cells.

Authors:  Joshua C Johnson; Osvaldo Martinez; Anna N Honko; Lisa E Hensley; Gene G Olinger; Christopher F Basler
Journal:  Antiviral Res       Date:  2014-05-09       Impact factor: 5.970

9.  An Ebola Virus-Like Particle-Based Reporter System Enables Evaluation of Antiviral Drugs In Vivo under Non-Biosafety Level 4 Conditions.

Authors:  Dapeng Li; Tan Chen; Yang Hu; Yu Zhou; Qingwei Liu; Dongming Zhou; Xia Jin; Zhong Huang
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

10.  A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity.

Authors:  Ari Watt; Felicien Moukambi; Logan Banadyga; Allison Groseth; Julie Callison; Astrid Herwig; Hideki Ebihara; Heinz Feldmann; Thomas Hoenen
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.